QPT:CA Quest PharmaTech Inc

CAD 0.03 0.00 0
Icon

Quest PharmaTech Inc (QPT:CA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | TSV
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.03

0.00 (0.00)%

CAD 0.02B

2.00K

N/A

N/A

Icon

QPT:CA

Quest PharmaTech Inc (CAD)
COMMON STOCK | TSV
CAD 0.03
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.02B

N/A

CAD 0.03

Quest PharmaTech Inc (QPT:CA) Stock Forecast

N/A

Based on the Quest PharmaTech Inc stock forecast from 0 analysts, the average analyst target price for Quest PharmaTech Inc is not available over the next 12 months. Quest PharmaTech Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Quest PharmaTech Inc is Slightly Bullish , which is based on 6 positive signals and 3 negative signals. At the last closing, Quest PharmaTech Inc’s stock price was CAD 0.03. Quest PharmaTech Inc’s stock price has changed by +0.00% over the past week, -37.50% over the past month and -64.29% over the last year.

No recent analyst target price found for Quest PharmaTech Inc
No recent average analyst rating found for Quest PharmaTech Inc

Company Overview Quest PharmaTech Inc

Quest PharmaTech Inc., a biopharmaceutical company, develops and commercializes antibody based immunotherapeutic products for cancer. Its lead product candidates are Mab AR 9.6 against truncated O-glycan on MUC16 for targeted cancer therapy applications; and Oregovomab, an anti-C...Read More

N/A

N/A

0

N/A

CAD

Canada

Adjusted Closing Price for Quest PharmaTech Inc (QPT:CA)

Loading...

Unadjusted Closing Price for Quest PharmaTech Inc (QPT:CA)

Loading...

Share Trading Volume for Quest PharmaTech Inc Shares

Loading...

Compare Performance of Quest PharmaTech Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for QPT:CA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Quest PharmaTech Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NGEN:CA
NervGen Pharma Corp 0.00 (0.00%) CAD0.10B N/A N/A

ETFs Containing QPT:CA

Symbol Name QPT:CA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Quest PharmaTech Inc (QPT:CA) Stock

Stock Target Advisor's fundamental analysis for Quest PharmaTech Inc's stock is Slightly Bullish .

Unfortunately we do not have enough data on QPT:CA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on QPT:CA's stock to indicate what its average analyst target is.

QPT:CA stock's Price/Earning ratio is 0.23. Our analysis grades QPT:CA stock's Price / Earning ratio at A+. This means that QPT:CA stock's Price/Earning ratio is above 0% of the stocks in the Biotechnology sector in the TSV exchange. Based on this QPT:CA may be undervalued for its sector.

The last closing price of QPT:CA's stock was CAD 0.03.

The most recent market capitalization for QPT:CA is CAD 0.02B.

Unfortunately we do not have enough analyst data on QPT:CA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Quest PharmaTech Inc's stock.

As per our most recent records Quest PharmaTech Inc has 0 Employees.

Sorry we do not have any infomation available on Quest PharmaTech Inc's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...